Sign for Notice Everyday    Sign Up| Sign In| Link|

Our Sponsors

  • ESTA - Electronic System for Travel Authorization
Receive Latest News

Feedburner
Share Us

Vendor-CRO-CMO Oversight in the (Biopharma) and Device Industry

View: 48

Website https://www.compliance4all.com/control/w_product/~product_id=502215LIVE?channel=ourglocal_Dec_2018_S | Edit Freely

Category Manufacturing, Pharmacovigilance, Compliance

Deadline: December 03, 2018 | Date: December 05, 2018

Venue/Country: Online, U.S.A

Updated: 2018-10-08 14:40:14 (GMT+9)

Call For Papers - CFP

Overview:

This webinar is specifically designed for sponsoring biopharma and device

companies who are outsourcing.It will help you get to grips with effective

Vendors (including CRO,CMO, and other vendors) management used in

the biopharma and device industries and your responsibilities as the

sponsor.

Areas Covered in the Session:

Setting up vendor oversight

Inspector expectations

Selection of CROs to meet oversight requirements

Ensuring clarity of roles and responsibilities

RFI and RFP

Contractual consideration for oversight

The oversight/quality plan

Who Will Benefit:

Regulatory

Manufacturing

Pharmacovigilance

Compliance

Audit

Quality

Speaker Profile:

Dr. Laura Brown , PhD, MBA, Diploma Clinical Sciences, is an independent

QA and training consultant in the pharmaceutical industry. She is a

managing director with LB Training and Development Ltd., course director

for the M.Sc. in Clinical Research, School of Pharmacy at the University of

Cardiff, and course director for M.Sc. Regulatory Affairs, TOPRA.

Event Fee: One Dial-in One Attendee Price: US$150.00

Contact Detail:

Compliance4All DBA NetZealous,

Phone: +1-800-447-9407

Email: support@compliance4All.com


Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.